Season 1 Ep 3 Dr Courtney Miller Co founder/CEO Myosin Therapeutics

In this episode Dr. Courtney Miller, a neuroscientist and co-founder of Myosin, discusses her journey in drug development for substance use disorder and glioblastoma. She shares how her team discovered a potential treatment for methamphetamine addiction and the progress they have made in developing it into a medication. Dr. Miller also highlights the challenges of fundraising in the biotech industry, particularly for areas like substance use disorder and glioblastoma. She emphasizes the importance of networking and self-promotion, especially for women in the field. Dr. Miller envisions bringing their treatments into the clinic and making a significant impact in the next five years. keywords neuroscience, drug development, substance use disorder, addiction, glioblastoma, fundraising, networking, self-promotion, biotech industry takeaways Drug development for substance use disorder and glioblastoma is a challenging and expensive journey. Networking and self-promotion are crucial for success in the biotech industry, especially for women. Taking advantage of opportunities and building a strong network can lead to unexpected career paths. Stigma surrounding substance use disorder hinders progress in developing effective treatments. Creating a narrative and leveraging personal connections can open doors and lead to valuable collaborations. Dr. Miller aims to bring their treatments into the clinic and make a significant impact in the next five years. titles Making a Significant Impact in Drug Development Challenges of Fundraising in the Biotech Industry Chapters 00:00 Introduction and Background 02:47 Discovery of Potential Treatment for Methamphetamine Addiction 08:23 Understanding Substance Use Disorder and Brain Changes 13:09 Challenges and Opportunities in Fundraising 20:22 The Importance of Networking and Self-Promotion 27:10 Overcoming Stigma and Building Strong Connections 35:43 Future Goals and Impact in Drug Development